FindTrial
Sign In

DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) Foundation Study

A randomised controlled trial of the DESMOND Foundation Programme for people with established Type 2 diabetes in a multi-ethnic population in Leicester and South Birmingham

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN25675619
Enrollment
640
Registered
2010-07-29
Start date
2010-08-26
Completion date
Unknown
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Established Type 2 diabetes mellitus (= 12 months < 10 years duration) Nutritional, Metabolic, Endocrine Non-insulin dependent diabetes mellitus

Interventions

The DESMOND structured group education programme for patients with established Type 2 diabetes. When delivered in English this a 6 hour programme (two sessions of 3 hours each) or when delivered in Gu

Sponsors

University Hospitals of Leicester NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients have established Type 2 diabetes of a duration = 12 months < 10 years duration 2. Not receiving insulin therapy 3. Controlling their diabetes by diet or any combination of OHAs (oral hypoglycaemic agents) 4. HbA1c = 7.0% and = 10.0% 5. Able to participate in a group programme 6. Age = 18 and < 75 years of age 7. South Asian patients whose first language is not English, will need to be Gujarati speaking (Leicester) or Urdu or Punjabi speaking (South Birmingham)

Exclusion criteria

Exclusion criteria: 1. Patients who have already attended a DESMOND programme 2. Unable to give informed consent 3. Severe and enduring mental health problems e.g. diagnosed with psychotic illness 4. Patient not primarily responsible for their own care 5. Unable to participate in a group programme (e.g. housebound) 6. Do not have Type 2 diabetes 7. Newly diagnosed with Type 2 diabetes (< 12 months) 8. Currently taking part in a research study 9. Receiving insulin therapy

Design outcomes

Primary

MeasureTime frame
HbA1c measured at 6 and 12 month follow up—

Secondary

MeasureTime frame
Measures at 6 and 12 month follow up: 1. Blood cholesterol 2. Body weight 3. Blood pressure 4. Waist and hip circumference 5. Lifestyle (smoking and physical activity) 6. Questionnaire tools listed below: 6.1 Illness Perception Questionnaire Revised (IPQ-R) 6.2 Diabetes Illness Representations Questionnaire (DIRQ) 6.3 The Hospital Anxiety & Depression Scale (HADS) 6.4 International Physical Activity Questionnaire (IPAQ) 6.5 Problem Areas in Diabetes Scales (PAIDS) 6.3 International Physical Activity Questionnaire (IPAQ)—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026